Keywords: Other Musculoskeletal, Treatment Response, soft tissue sarcoma; Neoadjuvant radiation therapy; Targeted Therapy
Motivation: The complexity and heterogeneity of soft tissue sarcomas (STS) create challenges in personalized treatment, underscoring the need for tools that can reveal tumor characteristics and their biological implications.
Goal(s): To evaluate the ability of MRI-based Delta-radiomics in classifying STS patients and explore its association with transcriptomic changes and immune microenvironment characteristics.
Approach: Prospective phase II trial with 84 STS patients, utilizing MRI for radiomic feature extraction and transcriptomic analysis to correlate gene expression with treatment response.
Results: Delta-radiomics stratified patients into distinct clusters, revealing significant correlations with gene expression profiles and immune response patterns, highlighting a comprehensive approach to treatment stratification in STS.
Impact: The integration of radiomics and transcriptomics in this study has revolutionized the understanding of STS, providing a non-invasive approach to uncover the genetic basis of disease. This fusion offers a comprehensive view of disease mechanisms, which can enhance personalized treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords